Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
OBEVIDOS
2023-507089-18-00Phase 3Authorised
- Sponsor
- Hospices Civils de Lyon
- Start
- Sep 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of cholecalciferol in Vitamin D deficiency (VDD) (2 arms), sponsored by Hospices Civils de Lyon. Primary endpoint: Serum 25-hydroxyvitamin D level at 3 months. Planned start Sep 2023; status: authorised.
02
Drugs
cholecalciferol
03
Conditions
Vitamin D deficiency (VDD)
Beyond the preview
Go deeper on 2023-507089-18-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2023-507089-18-00.